Across TCGA pan-cancer cohorts, FAM133CP RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated FAM133CP data layer.
The strongest signal is observed in kidney chromophobe (KICH), where higher FAM133CP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAM133CP expression acts as an unfavorable survival marker, although some lineages such as LUSC and THYM show a favorable association.
KICH, KIRC, and LUSC are the cancer types where FAM133CP RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.